Anti-drug Antibodies Against a Novel Humanized Anti-CD20 Antibody Impair Its Therapeutic Effect on Primary Biliary Cholangitis in Human CD20- and FcγR-Expressing Mice-Reference-Cited by-同舟云学术

Anti-drug Antibodies Against a Novel Humanized Anti-CD20 Antibody Impair Its Therapeutic Effect on Primary Biliary Cholangitis in Human CD20- and FcγR-Expressing Mice

Published:2018-11-02 Issue: Volume:9 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Moritoki Yuki,Tsuneyama Koichi,Nakamura Yuka,Kikuchi Kentaro,Shiota Akira,Ohsugi Yoshiyuki,Lian Zhe-Xiong,Zhang Weici,Yang Guo-Xiang,Ueki Shigeharu,Takeda Masahide,Omokawa Ayumi,Saga Tomoo,Saga Akiko,Watanabe Daisuke,Miura Masahito,Ueno Yoshiyuki,Leung Patrick S. C.,Tanaka Atsushi,Gershwin M. Eric,Hirokawa Makoto

Funder

Japan Society for the Promotion of Science

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference74 articles.

1. Changing nomenclature for PBC: from ‘cirrhosis’ to ‘cholangitis’;Beuers;Hepatology,2015

2. Primary biliary cirrhosis: an orchestrated immune response against epithelial cells;Gershwin;Immunol Rev.,2000

3. Primary biliary cirrhosis;Kaplan;N Engl J Med.,2005

4. Distribution of B lymphocytes in nonsuppurative cholangitis in primary biliary cirrhosis;Nakanuma;Hepatology,1993

5. Identification of HLA-A2-restricted CD8(+) cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells;Kita;J Exp Med.,2002

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular insights into experimental models and therapeutics for cholestasis;Biomedicine & Pharmacotherapy;2024-05

2. Cellular Interactions and Crosstalk Facilitating Biliary Fibrosis in Cholestasis;Cellular and Molecular Gastroenterology and Hepatology;2024

3. Animal models of primary biliary cholangitis: status and challenges;Cell & Bioscience;2023-11-22

4. Mechanism-based target therapy in primary biliary cholangitis: opportunities before liver cirrhosis?;Frontiers in Immunology;2023-05-30

5. The pathogenesis, models and therapeutic advances of primary biliary cholangitis;Biomedicine & Pharmacotherapy;2021-08